Your search found 4 Results
Changes in antiretroviral therapy guidelines: implications for public health policy and public purses.
Sexually Transmitted Infections. 2010 Oct; 86(5):388-90.INTRODUCTION: The World Health Organization (WHO) published a revision of the antiretroviral therapy (ART) guidelines and now recommends ART for all those with a CD4 cell count =350/mm(3), for people with HIV and active tuberculosis (TB) or chronic active hepatitis B irrespective of CD4 cell count and all HIV-positive pregnant women. A study was undertaken to estimate the impact of the new guidelines using four countries as examples. METHODS: The current WHO/UNAIDS country projections were accessed based on the 2007 estimates for Zambia, Kenya, Cameroon and Vietnam. New projections were created using Spectrum. CD4 progression rates to need for ART were modified and compared with the baseline projections. RESULTS: The pattern of increased need for treatment is similar across the four projections. Initiating treatment at a CD4 count <250/mm(3) will increase the need for treatment by a median of 22% immediately, initiating ART at a CD4 count <350/mm(3) increases the need for treatment by a median of 60%, and the need for treatment doubles if ART is commenced at a CD4 count <500/mm(3). Initiating ART at a CD4 cell count <250/mm(3) would increase the need for treatment by a median of around 15% in 2012; initiating treatment at a CD4 count <350/mm(3) increases the need for treatment by a median of 42% across the same projections and about 84% if CD4 <500/mm(3) was used. CONCLUSIONS: The projections indicate that initiating ART earlier in the course of the disease by increasing the threshold for the initiation of ART would increase the numbers of adults in need of treatment immediately and in the future.
Geneva, Switzerland, WHO, 2009 Nov. 25 p.Based on the latest scientific evidence, the World Health Organization (WHO) has released new recommendations on HIV treatment and prevention and infant feeding in the context of HIV. WHO now recommends earlier initiation of antiretroviral therapy for adults and adolescents, the delivery of more patient-friendly antiretroviral drugs (ARVs), and prolonged use of ARVs to reduce the risk of mother-to-child transmission of HIV. For the first time, WHO recommends that HIV-positive mothers or their infants take ARVs while breastfeeding to prevent HIV transmission.
Implementing the ICPD Plan of Action in Central Asian Republics and Kazakhstan (CARAK). Kyrgyzstan. Breast-feeding is best.
ENTRE NOUS. 1995 May; (28-29):11.The socioeconomic problems which began in Kyrgyzstan in 1990 have impacted on the health of the people living there. A major decline in income, living standards, and social security is reflected in the low fertility rate, high maternal and infant mortality, and shorter life expectancy. Tuberculosis, viral hepatitis, anemia, hypertrophy, and rachitis have become very common in young children. In order to remedy this situation, breast feeding has gained the importance of a national program. Other unresolved issues include the high neonatal mortality rate, and the increasing maternal mortality rate (from 76.4 per 100,000 live births in 1991 to 84.2 per 100,000 currently). There has been a functioning family planning service and a system of social patronage since 1989. In the latter system, a social worker takes charge of families at risk. One worker on average attends 30 families. The International Planned Parenthood Federation has financed 689 social patronage workers over the past year. International organizations have supported the supply of contraceptives through humanitarian aid. Because of this, the number of women accepting family planning is rising and the fertility rate is decreasing (from 28.2 per 1000 in 1991 to 26.9 in 1993).
ANALES ESPANOLES DE PEDIATRIA. 1992 Jun; 36 Suppl 48:189.New vaccine developments will reflect achievements of the World Health Organization's (WHO) Expanded Programme on Immunization (EPI), as well as resistance from the public toward increasing numbers of vaccines. WHO's EPI program has concentrated on tuberculosis, diphtheria, tetanus, whooping cough, polio, and measles. 35 countries are attempting to control hepatitis B with universal vaccination. Now some countries are also recommending vaccination against Haemophilus influenza, mumps, and rubella. The complexity of multiple injections has prompted new research on acellular vaccines for pertussis, hepatitis A and B, varicella, and malaria. Combined vaccines and new adjuvants are also targets of intense research. Vaccines are a priority, because they are among the most cost-effective of medical interventions.